Message Font: Serif | Sans-Serif
No. of Recommendations: 2
INTRO Here's my semi-annual exercise to see if I remember why I own the stocks I own, and so I can check back and see if their stories have changed. I post in case it helps others too.

GERN (market cap $0.493B)
Geron is a leading edge biotech company focusing (and please excuse the spelling) on stem cells, nuclear cell transfer, telomorase, etc. Basically, they hope to be able to regrow cells to regenerate organs and nerves; and to control cell life and death via telomorase, thereby controlling cancer and possibly prolonging life. They have begun clinical trials and have been delayed by a very cautious FDA.

Geron and GERN continue to be highly speculative in many ways: company, technology, treatment and stock. This will change with progress through the clinical trials, which will take a few more years. That's an improvement because years ago the wait was several years.

I continue to HOLD, and would consider buying more if cash were available and if clinical trials showed dramatic results. Dramatic results are possible considering the impact of accident victims walking again, or cancer patients finding their tumors have shrunk. I don't know if such results are probable, but they do seem possible.

Print the post  


What was Your Dumbest Investment?
Share it with us -- and learn from others' stories of flubs.
When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.